Serum Concentration of MMP-9 as a Predictive Biomarker for the Progression of Oral Cancer.
Journal:
Journal of maxillofacial and oral surgery
Published Date:
May 12, 2023
Abstract
BACKGROUND: Oral cancer is the most prominent cancer subtype among all head and neck cancers, the incidence and prevalence of which has been consistently increasing in past years around the globe. At advanced stages, oral cancer imparts significant mortality, morbidity, and mutilation among the patients, and therefore, diagnosis and treatment of the disease at early stages are considered the optimum strategy for the management of the disease. Since molecular changes appear earlier than physical symptoms, several molecular biomarkers are currently being investigated for their role in diagnosing and treating disease. MMP-9 belongs to the family of proteinases that are involved in cytoskeletal degradation, which is a crucial phase of cancer progression.
Authors
Keywords
No keywords available for this article.